February 27, 2023: BetaGlue Technologies: the Shareholders’ Meeting renews the BoD, Dr Colin Story appointed CEO

October 19, 2022: BetaGlue Technologies strengthen its expertise in strategic areas with four managers

July 19, 2022: BetaGlue Technologies: closing of a EUR 10 million financing round

 

July 11, 2022: BetaGlue takes radiotherapy inside solid tumours: first patient treated with BAT-90